Cancer Research UK and SV Health Investors have allied to accelerate development of cancer drugs. CRUK is set to invest $25 million in SV’s new biotech fund and work with its new partner to pick ...

Italy, and clinically tested by the Experimental Cancer Medicine Centre based at Guy’s Hospital. The study, funded and sponsored by Cancer Research UK, is published in Nature Communications.

Biotecnol has teamed up with Cancer Research UK (CRUK) to take its T-cell engager into the clinic. The agreement sees CRUK take a stake in the Anglo-Portuguese biotech in return for help testing a ...

CRH, which is the innovation arm of the charity Cancer Research UK (CRUK) operates as a clinical developer ‘with a twist’. It can offer the operational skills and network of scientific and ...

Cancer Research UK (CRUK) has launched the second phase of its Grand Challenge program, which awards funding to interdisciplinary research teams from around the world to help address some of the ...

The team from Cancer Research UK's Manchester Institute says it has created a new in vitro model of lung squamous cell carcinoma (LUSC) – which accounts for almost a third of all non-small cell ...